#obesity-treatment

Ascletis Announces Positive Preclinical Data for the Most Comprehensive Once-Weekly Oral Peptide Pipeline for the Treatment of Obesity

Ascletis reported positive preclinical data for its once-weekly oral peptide pipeline targeting obesity and metabolic disorders. The comprehensive portfolio covers four validated therapeutic targets with potential first-in-class fixed-dose combinations.